AU7695891A - Treatment of autoimmune diseases - Google Patents

Treatment of autoimmune diseases

Info

Publication number
AU7695891A
AU7695891A AU76958/91A AU7695891A AU7695891A AU 7695891 A AU7695891 A AU 7695891A AU 76958/91 A AU76958/91 A AU 76958/91A AU 7695891 A AU7695891 A AU 7695891A AU 7695891 A AU7695891 A AU 7695891A
Authority
AU
Australia
Prior art keywords
treatment
autoimmune diseases
autoimmune
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76958/91A
Inventor
David Trentham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Hospital Association
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital Association filed Critical Beth Israel Hospital Association
Publication of AU7695891A publication Critical patent/AU7695891A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU76958/91A 1990-04-03 1991-04-03 Treatment of autoimmune diseases Abandoned AU7695891A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50419890A 1990-04-03 1990-04-03
US504198 1990-04-03

Publications (1)

Publication Number Publication Date
AU7695891A true AU7695891A (en) 1991-10-30

Family

ID=24005263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76958/91A Abandoned AU7695891A (en) 1990-04-03 1991-04-03 Treatment of autoimmune diseases

Country Status (2)

Country Link
AU (1) AU7695891A (en)
WO (1) WO1991015236A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591719A (en) * 1992-12-10 1997-01-07 Regents Of The University Of Minnesota Method for treating acute and chronic inflammatory disorders using polypeptides with fibronectin activity
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677064A (en) * 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor

Also Published As

Publication number Publication date
WO1991015236A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
AU639192B2 (en) Treatment of water
AU674894C (en) Treatment of conditions and disease
AU7867994A (en) Hemofiltration of mediator-related diseases
AU6434390A (en) Treatment of ards
AU8910891A (en) Treatment of lung diseases
AU8153794A (en) Methods of inhibiting autoimmune diseases
GB2223959B (en) Treatment of nitrophenolic by-products
AU6974687A (en) Treatment of immune diseases using diphenylhydantoin
AU6660090A (en) Treatment of depression
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
AU5340594A (en) Skin treatment
AU3836489A (en) Treatment of immunodeficiency
AU8185491A (en) Treatment of disease
ZA935647B (en) Treatment of sickle cell disease
AU8879691A (en) Treatment of dispersions
AU7695891A (en) Treatment of autoimmune diseases
AU8083591A (en) Therapy and prophylaxis of autoimmune diseases
AU4017389A (en) Use of paf-antagonists for treating autoimmune diseases
AU6863191A (en) Treatment of protozoal diseases
AU1593792A (en) Treatment of mastitis
AU8819691A (en) Treatment of gas
AU3163795A (en) Treatment of autoimmune diseases
AU7646994A (en) Treatment of autoimmune disease
GB9216360D0 (en) Treatment of blood
AU7323091A (en) Treatment of wastewater